Soluble Vascular Cell Adhesion Molecule-1 and E-Selectin in Patients With Acute Myocardial Infarction Treated With Thrombolytic Agents
- 15 March 1998
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 81 (6) , 772-775
- https://doi.org/10.1016/s0002-9149(97)01035-7
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Circulating Vascular Cell Adhesion Molecule-1 Correlates With the Extent of Human Atherosclerosis in Contrast to Circulating Intercellular Adhesion Molecule-1, E-Selectin, P-Selectin, and ThrombomodulinArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- The selecting: vascular adhesion moleculesThe FASEB Journal, 1995
- Cytokines Regulate Vascular Functions Related to Stability of the Atherosclerotic PlaqueJournal of Cardiovascular Pharmacology, 1995
- Role of selectins, a new family of adhesion molecules, in ischaemia-reperfusion injuryCardiovascular Research, 1994
- Circulating adhesion molecules in diseaseImmunology Today, 1993
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab thrombolytic therapy: Results of the thrombolysis and angioplasty in mycardial infaraction (TAMI) 8 pilot studyJournal of the American College of Cardiology, 1993
- Regulation of VCAM-1 Expression and Involvement in Cell Adhesion to Murine Microvascular EndotheliumCellular Immunology, 1993
- Selectins.Journal of Clinical Investigation, 1993
- Role of endothelial-leukocyte adhesion molecule 1 (ELAM-1) in neutrophil-mediated lung injury in rats.Journal of Clinical Investigation, 1991